September 11, 2018
Stock exchange release
Free for publication on September 11, 2018 at 10.15am (CEST +1)
Appointment in Bittium Corporation’s management group
Mr. Sammy Loitto appointed as Senior Vice President, Sales
Mr. Sammy Loitto (MBA and Master of Engineering in Industrial Management) has been appointed as Senior Vice President, Sales in Bittium Corporation as of October 1, 2018. Previously he has been responsible for sales and business development activities at Bittium. Prior to that, he has worked in several sales and management positions at Jolla, Gryphon Secure and Airbus. Mr. Loitto reports to Mr. Hannu Huttunen, CEO of Bittium Corporation.
“Bittium has been significantly investing in the development of its own products and product platforms. Now we are investing in the development and growth of our sales and international sales network. Sammy has extensive experience in several international sales management and development positions and strong expertise in the public safety markets. This creates a good foundation for the development of Bittium’s sales and sales network”, says Hannu Huttunen, CEO of Bittium Corporation.
As of October 1, 2018 Bittium management group consists of following persons: Mr. Hannu Huttunen, CEO (chairman); Mr. Pekka Kunnari, CFO; Mr. Kari Jokela, CLO; Ms. Karoliina Fyrstén, Director, Corporate Communications and Marketing, Mr. Sammy Loitto, Senior Vice President Sales, and heads of product and service areas: Mr. Jari Sankala, Senior Vice President, Defense and Security; Mr. Klaus Mäntysaari, Senior Vice President, Connectivity Solutions; and Mr. Arto Pietilä, Senior Vice President, Medical Technologies; and Mr. Jari-Pekka Innanen, Vice President, Engineering.
Oulu, September 11, 2018
Tel. +358 40 344 3507
Nasdaq Helsinki Ltd
Bittium specializes in the development of reliable, secure communications and connectivity solutions, leveraging its 30 year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. Bittium also offers healthcare technology products and services for the measurement of and monitoring of biosignals in the areas of cardiology, neurology, rehabilitation, occupational health and sports medicine. Net sales in 2017 were EUR 51.6 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com